pharma · Invasive Extraintestinal Pathogenic Escherichia coli Disease · HIV-1 Infection
Zhejiang Xianju Pharmaceutical
Xian-Janssen Pharmaceutical
Zhejiang Xianju Pharmaceutical clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
西安, CN HQ
146 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- 西安, CN
- Employees
- 146
- Programs
- 2
- Drugs
- 5
- Patents
- 0
Zhejiang Xianju Pharmaceutical projects
2 ClinicalTrials.gov programs sponsored by Zhejiang Xianju Pharmaceutical.
Zhejiang Xianju Pharmaceutical has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Zhejiang Xianju Pharmaceutical have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.